Contact Us / Request a Quote Download Manuals
Advanced Cell Diagnostics Advanced Cell Diagnostics

Search form

Please sign in
  • Log In
  • Register
  • How to Order
  • What to Buy
0 My Cart
X

You have no items in your shopping cart.

Menu
X
  • Products +
    RNAscope™/BaseScope™/ miRNAscope™
    +
    • Assay Selection Guide
    Target Probes
    +
    • All About Probes
    • Catalog Probes
    • Probe Sets
    • New Probe Request
    Manual Assays
    +
    RNAscope™ Chromogenic
    • Overview
    • RNAscope™ 2.5 HD Assay-Brown
    • RNAscope™ 2.5 HD Assay-Red
    • RNAscope™ 2.5 HD Duplex Assay
    RNAscope™ Multiplex Fluorescent
    • Overview
    • RNAscope™ HiPlex v2 Assay
    • RNAscope™ Multiplex Fluorescent V2
    BaseScope™
    • Overview
    • BaseScope™ Assay Red
    • BaseScope™ Duplex Assay
    miRNAscope™
    • Overview
    • miRNAscope™ Assay red
    • RNAscope™ Plus smRNA-RNA Assay
    DNAscope™
    • Overview
    • DNAscope™ Duplex Assay
    Automated Assays
    +
    For Lunaphore COMET™
    • RNAscope™ HiPlex Pro for COMET™
    For Leica systems
    • Overview
    • RNAscope™ 2.5 LS Assay-Brown
    • RNAscope™ 2.5 LS Assay-Red
    • RNAscope™ 2.5 LS Duplex Assay
    • RNAscope™ Multiomic LS Assay
    • RNAscope™ 2.5 LS Fluorescent Multiplex Assay
    • RNAscope™ 2.5 LSx Reagent Kit-BROWN
    • RNAscope™ 2.5 LSx Reagent Kit-RED
    • BaseScope™ LS Reagent Kit – RED
    • miRNAscope LS Reagent Kit Red
    • RNAscope™ Plus smRNA-RNA LS Assay
    Roche DISCOVERY ULTRA system
    • Overview
    • RNAscope™ VS Universal HRP
    • RNAscope™ VS Universal AP
    • RNAscope™ VS Duplex Assay
    • BaseScope™ VS Reagent Kit – RED
    RNA-Protein Co-Detection Assay
    +
    • RNAscope HiPlex-IMC™ Co-Detection
    • Integrated Codetection Assay
    • Sequential RNA Protein Detection
    Software
    +
    • Overview
    • Aperio RNA ISH Algorithm
    • HALO® image analysis platform
    Controls & Accessories
    +
    • RNAscope™
    • BaseScope™
    • miRNAscope™
    • Accessories
    How to Order
    +
    • Ordering Instructions
    • What to Buy
  • Services +
    Professional Assay Services
    +
    • Our Services
    • Multiomic Services
    • Biomarker Assay Development
    • Cell & Gene Therapy Services
    • Clinical Assay Development
    • Tissue Bank & Sample Procurement
    • Image Analysis
    Benefits
    +
    • Your Benefits
    • Certified Providers
    How to Order
    +
    • Ordering Process
    • Contact Services
  • Areas of Research +
    Most Popular
    +
    • COVID-19 Coronavirus
    • Single Cell Analysis
    • Whole-Mount
    • Anatomic Pathology Panels
    • Neuroscience
    • Inflammation
    • Gene Therapy/AAV
    • Stem Cell
    • Immuno-oncology
    • Liver Research
    • Cardiovascular & Skeletal Muscle Research
    Cell & Gene Therapy
    +
    • Gene Therapy
    • Gene Therapy/AAV
    • siRNA/ASO
    • Cell Therapy
    Cancer
    +
    • Breast Cancer
    • EGFRvIII Splice Variant
    • HPV Related Cancer
    • Immuno-oncology
    • Lung Cancer
    • PDx
    • Prostate Cancer
    • Point Mutation
    • CDR3 for TCR
    Viral
    +
    • COVID-19 Coronavirus
    • HIV & SIV
    • Infectious Disease
    • Zika Virus
    Pathways
    +
    • AKT
    • JAK STAT
    • WNT B-Catenin
    Neuroscience
    +
    Neuroscience
    • Neural Development
    • Neuronal Cell Types
    • Learning and Memory
    • G-protein-coupled Receptors & Ion Channels
    • Post-mortem Brain Tissue
    Other
    +
    • Circular RNA
    • Gene Fusions
    • HT Transcript Validation
    • Long Non-coding RNA
    • RNAseq Validation
    • Single Cell Analysis
    • Splice Variant
    • miRNA
    RNA & Protein
    +
    • Antibody Challenges
    • Dual ISH + IHC Methods
    • No Antibodies
    • RNA & Protein Analysis
    Customer Innovations
    +
    • Dual RNA+DNA ISH
    • Very old FFPE ISH
    • Wholemount ISH
    Animal Models
    +
    • Any Species
    • Mouse Model
    • Preclincal Safety
  • Technology +
    Overview
    +
    • How it Works
    • Data Image Gallery
    • Technology Video
    • Webinars
    RNA Detection
    +
    • Why RNA?
    • RNA ISH and IHC
    Pretreatment Options
    +
    • RNAscope™ Pretreatment
    • PretreatPro™
    Spotlights
    +
    • Researchers Spotlights
    • RNA & DNA
    • WISH
    • FFPE
    • Testimonials
    Publications, Guides & Posters
    +
    • Search publications
    • RNAscope™ Reference Guide
    • RNAscope™ Data Analysis Guide
    • Download RNAscope™ Posters
  • Support +
    Overview
    +
    • Get Started
    • How to Order
    • Distributors
    • Contact Support
    Troubleshooting
    +
    • Troubleshooting Guide
    • FAQs
    • User Manuals, SDS and Product Inserts
    • Documents and Downloads
    Imaging Resource
    +
    • Image Analysis
    • Image Registration Software
    • QuPath
    • HALO® image analysis platform
    Learn More
    +
    • Webinars
    • Training Videos
  • Partners +
    Partners
    +
    • Overview
    Partners Directory
    +
    Automation Partners
    • Leica Biosystem
    • Roche Diagnostics
    Workflow Partners
    • NanoString
    Software Partners
    • indica labs
    Become a Partner
    +
    • Learn How
  • Diagnostics +
    Diagnostics
    +
    • Diagnostics
    • Literature
    • Diagnostics ASR Probes
    • Diagnostics CE-IVD Probes
    • Diagnostics CE-IVD Detection
    • Companion Diagnostics
  • Image Calendar +
    Image Calendar
    +
    • Image Contest
    • Data Image Gallery
Search

Probes for INS

ACD can configure probes for the various manual and automated assays for INS for RNAscope Assay, or for Basescope Assay compatible for your species of interest.

  • Probes for INS (0)
  • Kits & Accessories (0)
  • Support & Documents (0)
  • Publications (968)
  • Image gallery (0)
Refine Probe List

Content for comparison

Gene

  • TBD (219) Apply TBD filter
  • SARS-CoV-2 (42) Apply SARS-CoV-2 filter
  • Lgr5 (12) Apply Lgr5 filter
  • vGlut2 (10) Apply vGlut2 filter
  • Gad1 (9) Apply Gad1 filter
  • FOS (8) Apply FOS filter
  • CD68 (7) Apply CD68 filter
  • SLC32A1 (6) Apply SLC32A1 filter
  • Oxtr (6) Apply Oxtr filter
  • VGAT (6) Apply VGAT filter
  • MALAT1 (5) Apply MALAT1 filter
  • TH (5) Apply TH filter
  • GLI1 (5) Apply GLI1 filter
  • Sst (5) Apply Sst filter
  • Gad2 (5) Apply Gad2 filter
  • Nos1 (5) Apply Nos1 filter
  • HPV (5) Apply HPV filter
  • HIV-1 (5) Apply HIV-1 filter
  • Axin2 (4) Apply Axin2 filter
  • Cnr2 (4) Apply Cnr2 filter
  • Ifng (4) Apply Ifng filter
  • DRD1 (4) Apply DRD1 filter
  • CAMK2D (4) Apply CAMK2D filter
  • Vegfa (4) Apply Vegfa filter
  • SCN5A (4) Apply SCN5A filter
  • Penk (4) Apply Penk filter
  • OLFM4 (4) Apply OLFM4 filter
  • TUBB3 (4) Apply TUBB3 filter
  • Crh (4) Apply Crh filter
  • Cacna1c (4) Apply Cacna1c filter
  • Slc17a6 (4) Apply Slc17a6 filter
  • OPRM1 (4) Apply OPRM1 filter
  • Nts (4) Apply Nts filter
  • RYR2 (4) Apply RYR2 filter
  • VGluT1 (4) Apply VGluT1 filter
  • Il-6 (4) Apply Il-6 filter
  • CB2R (4) Apply CB2R filter
  • HER2 (4) Apply HER2 filter
  • Tgf-β1 (4) Apply Tgf-β1 filter
  • SARS-CoV-2  (4) Apply SARS-CoV-2  filter
  • 18 (4) Apply 18 filter
  • 31 (4) Apply 31 filter
  • Sox9 (3) Apply Sox9 filter
  • IL17A (3) Apply IL17A filter
  • COL1A1 (3) Apply COL1A1 filter
  • CD44 (3) Apply CD44 filter
  • KRT19 (3) Apply KRT19 filter
  • Ccl2 (3) Apply Ccl2 filter
  • FGFR1 (3) Apply FGFR1 filter
  • GFAP (3) Apply GFAP filter

Product

  • (-) Remove RNAscope filter RNAscope (968)

Research area

  • Neuroscience (251) Apply Neuroscience filter
  • Cancer (177) Apply Cancer filter
  • Development (72) Apply Development filter
  • Inflammation (67) Apply Inflammation filter
  • Covid (50) Apply Covid filter
  • Other: Methods (36) Apply Other: Methods filter
  • Pain (34) Apply Pain filter
  • HPV (32) Apply HPV filter
  • Infectious (29) Apply Infectious filter
  • Stem Cells (25) Apply Stem Cells filter
  • CGT (20) Apply CGT filter
  • Metabolism (17) Apply Metabolism filter
  • Immunotherapy (16) Apply Immunotherapy filter
  • Other: Heart (14) Apply Other: Heart filter
  • LncRNAs (13) Apply LncRNAs filter
  • HIV (12) Apply HIV filter
  • Infectious Disease (12) Apply Infectious Disease filter
  • Other: Kidney (12) Apply Other: Kidney filter
  • Reproduction (12) Apply Reproduction filter
  • Stem cell (12) Apply Stem cell filter
  • Endocrinology (10) Apply Endocrinology filter
  • Obesity (10) Apply Obesity filter
  • Other: Liver (10) Apply Other: Liver filter
  • Aging (8) Apply Aging filter
  • Heart (8) Apply Heart filter
  • lncRNA (8) Apply lncRNA filter
  • Other: Metabolism (8) Apply Other: Metabolism filter
  • Other: Zoological Disease (8) Apply Other: Zoological Disease filter
  • Alzheimer's Disease (7) Apply Alzheimer's Disease filter
  • Behavior (7) Apply Behavior filter
  • Itch (7) Apply Itch filter
  • Liver (7) Apply Liver filter
  • Psychiatry (7) Apply Psychiatry filter
  • diabetes (6) Apply diabetes filter
  • Other: Lung (6) Apply Other: Lung filter
  • Other: Ophthalmology (6) Apply Other: Ophthalmology filter
  • Stress (6) Apply Stress filter
  • Other: Endocrinology (5) Apply Other: Endocrinology filter
  • Addiction (4) Apply Addiction filter
  • Anxiety (4) Apply Anxiety filter
  • Bone (4) Apply Bone filter
  • Gastroenterology (4) Apply Gastroenterology filter
  • Immunology (4) Apply Immunology filter
  • Lung (4) Apply Lung filter
  • Neuroinflammation (4) Apply Neuroinflammation filter
  • Other: Heart Disease (4) Apply Other: Heart Disease filter
  • Teeth (4) Apply Teeth filter
  • Transcriptomics (4) Apply Transcriptomics filter
  • Tumor microenvironment (4) Apply Tumor microenvironment filter
  • Vaccines (4) Apply Vaccines filter

Category

  • Publications (968) Apply Publications filter
ROC Analysis of p16 Expression in Cell Blocks of Metastatic Head and Neck Squamous Cell Carcinoma

Journal of the American Society of Cytopathology

2021 Apr 01

Wilson, B;Israel, A;Ettel, M;Lott Limbach, A;
| DOI: 10.1016/j.jasc.2021.03.004

Background Oropharyngeal squamous cell carcinoma is associated with human papillomavirus (HPV) and often presents with early metastasis to cervical neck lymph nodes which are amenable to fine needle aspiration (FNA). The most common method of HPV status determination is p16 immunohistochemistry (IHC). The literature suggests that a lower threshold is needed for p16 positivity on cell block. We examined and quantified p16 IHC staining on cell block and used ROC curve analysis to determine an optimal cut off value with high sensitivity and specificity. Methods Thirty-six FNAs of metastatic squamous cell carcinoma from cervical lymph nodes with p16 IHC were evaluated. The p16 stain was quantified in 5% increments and HR-HPV mRNA ISH was performed as a gold standard test. Statistical analysis was performed. Results Interobserver variability was evaluated and was shown to be low with an intraclass correlation coefficient of 0.857. Receiver operating characteristics (ROC) analysis was performed and showed that a cell block p16 IHC cut-off of 15% yielded the highest sensitivity (80%) and specificity (81.8%). Conclusion Our data shows that a threshold of 15% p16 staining in cell block maximizes sensitivity and specificity.
Double-stranded RNA immunohistochemistry as a screening tool for viral encephalitis

American journal of clinical pathology

2023 May 04

Piantadosi, A;Shariatzadeh, N;Bombin, A;Arkun, K;Alexandrescu, S;Kleinschmidt-DeMasters, BK;Solomon, IH;
PMID: 37141170 | DOI: 10.1093/ajcp/aqad039

Viral infections of the central nervous system can be challenging to diagnose because of the wide range of causative agents and nonspecific histologic features. We sought to determine whether detection of double-stranded RNA (dsRNA), produced during active RNA and DNA viral infections, could be used to select cases for metagenomic next-generation sequencing (mNGS) from formalin-fixed, paraffin-embedded brain tissue.Eight commercially available anti-dsRNA antibodies were optimized for immunohistochemistry (IHC) and the top antibody tested in a series of cases with confirmed viral infections (n = 34) and cases with inflammatory brain lesions of unclear etiology (n = 62).Among known positives, anti-dsRNA IHC produced a strong cytoplasmic or nuclear staining pattern for Powassan virus, West Nile virus, rabies virus, JC polyoma virus, and adenovirus while failing to detect Eastern equine encephalitis virus, Jamestown Canyon virus, or any herpesvirus. All the unknown cases were negative by anti-dsRNA IHC, while mNGS detected rare viral reads (0.3-1.3 reads per million total reads) in 2 cases (3%), with only 1 having potential clinical significance.Anti-dsRNA IHC can effectively identify a subset of clinically relevant viral infections but not all. The absence of staining should not exclude cases from mNGS if sufficient clinical and histologic suspicion exists.
Single-cell transcriptomic landscape of the developing human spinal cord

Nature neuroscience

2023 Apr 24

Andersen, J;Thom, N;Shadrach, JL;Chen, X;Onesto, MM;Amin, ND;Yoon, SJ;Li, L;Greenleaf, WJ;Müller, F;Pașca, AM;Kaltschmidt, JA;Pașca, SP;
PMID: 37095394 | DOI: 10.1038/s41593-023-01311-w

Understanding spinal cord assembly is essential to elucidate how motor behavior is controlled and how disorders arise. The human spinal cord is exquisitely organized, and this complex organization contributes to the diversity and intricacy of motor behavior and sensory processing. But how this complexity arises at the cellular level in the human spinal cord remains unknown. Here we transcriptomically profiled the midgestation human spinal cord with single-cell resolution and discovered remarkable heterogeneity across and within cell types. Glia displayed diversity related to positional identity along the dorso-ventral and rostro-caudal axes, while astrocytes with specialized transcriptional programs mapped into white and gray matter subtypes. Motor neurons clustered at this stage into groups suggestive of alpha and gamma neurons. We also integrated our data with multiple existing datasets of the developing human spinal cord spanning 22 weeks of gestation to investigate the cell diversity over time. Together with mapping of disease-related genes, this transcriptomic mapping of the developing human spinal cord opens new avenues for interrogating the cellular basis of motor control in humans and guides human stem cell-based models of disease.
Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function

Nature communications

2023 Apr 28

Jami, S;Deuis, JR;Klasfauseweh, T;Cheng, X;Kurdyukov, S;Chung, F;Okorokov, AL;Li, S;Zhang, J;Cristofori-Armstrong, B;Israel, MR;Ju, RJ;Robinson, SD;Zhao, P;Ragnarsson, L;Andersson, Å;Tran, P;Schendel, V;McMahon, KL;Tran, HNT;Chin, YK;Zhu, Y;Liu, J;Crawford, T;Purushothamvasan, S;Habib, AM;Andersson, DA;Rash, LD;Wood, JN;Zhao, J;Stehbens, SJ;Mobli, M;Leffler, A;Jiang, D;Cox, JJ;Waxman, SG;Dib-Hajj, SD;Gregory Neely, G;Durek, T;Vetter, I;
PMID: 37117223 | DOI: 10.1038/s41467-023-37963-2

Voltage-gated sodium (NaV) channels are critical regulators of neuronal excitability and are targeted by many toxins that directly interact with the pore-forming α subunit, typically via extracellular loops of the voltage-sensing domains, or residues forming part of the pore domain. Excelsatoxin A (ExTxA), a pain-causing knottin peptide from the Australian stinging tree Dendrocnide excelsa, is the first reported plant-derived NaV channel modulating peptide toxin. Here we show that TMEM233, a member of the dispanin family of transmembrane proteins expressed in sensory neurons, is essential for pharmacological activity of ExTxA at NaV channels, and that co-expression of TMEM233 modulates the gating properties of NaV1.7. These findings identify TMEM233 as a previously unknown NaV1.7-interacting protein, position TMEM233 and the dispanins as accessory proteins that are indispensable for toxin-mediated effects on NaV channel gating, and provide important insights into the function of NaV channels in sensory neurons.
Anti-HERV-K Drugs and Vaccines, Possible Therapies against Tumors

Vaccines

2023 Mar 28

Hosseiniporgham, S;Sechi, LA;
PMID: 37112663 | DOI: 10.3390/vaccines11040751

The footprint of human endogenous retroviruses (HERV), specifically HERV-K, has been found in malignancies, such as melanoma, teratocarcinoma, osteosarcoma, breast cancer, lymphoma, and ovary and prostate cancers. HERV-K is characterized as the most biologically active HERV due to possession of open reading frames (ORF) for all Gag, Pol, and Env genes, which enables it to be more infective and obstructive towards specific cell lines and other exogenous viruses, respectively. Some factors might contribute to carcinogenicity and at least one of them has been recognized in various tumors, including overexpression/methylation of long interspersed nuclear element 1 (LINE-1), HERV-K Gag, and Env genes themselves plus their transcripts and protein products, and HERV-K reverse transcriptase (RT). Therapies effective for HERV-K-associated tumors mostly target invasive autoimmune responses or growth of tumors through suppression of HERV-K Gag or Env protein and RT. To design new therapeutic options, more studies are needed to better understand whether HERV-K and its products (Gag/Env transcripts and HERV-K proteins/RT) are the initiators of tumor formation or just the disorder's developers. Accordingly, this review aims to present evidence that highlights the association between HERV-K and tumorigenicity and introduces some of the available or potential therapies against HERV-K-induced tumors.
Modeling Pkd1 gene-targeted strategies for correction of polycystic kidney disease

Molecular Therapy - Methods & Clinical Development

2023 Apr 01

Kurbegovic, A;Pacis, R;Trudel, M;
| DOI: 10.1016/j.omtm.2023.03.016

Autosomal dominant polycystic kidney disease (ADPKD) causes renal cysts and leads to end-stage-renal-disease in midlife due mainly to PKD1 gene mutations. Virtually no studies have explored gene therapeutic strategies for long-term effective treatment of PKD. Toward this aim, the severely cystic Pkd1 null mouse model was targeted by series of transgene transfer using genomic Pkd1 under its regulatory elements (Pkd1wt), kidney-targeted Pkd1 gene (SBPkd1) or Pkd1Minigene. The introduced Pkd1 wt gene constructs with ∼8-fold overexpression display similar endogenous cellular profile, full complementation of Pkd1-/- phenotype and establish the referral Pkd1 genomic length for proper regulation. SBPkd1 transgene transfers expressing 0.6- or 7-fold Pkd1 endogenous levels are sufficient to correct glomerular and proximal tubular cysts as well as markedly postpone cysts in other tubular segments, showing that the small SB elements appreciably overlap with Pkd1 promoter/5’UTR regulation. Renal targeted Pkd1Minigene at high-copy conveys similar expression level to endogenous Pkd1 gene with widespread and homogeneous weak Pkd1 cellular signal, partially rescuing all cystic tubular segments. These transgene transfers determine that Pkd1 intragenic sequences not only regulate expression levels but also spatiotemporal pattern. Importantly, our study demonstrates that Pkd1 re-expression from hybrid therapeutic constructs can ameliorate, with considerably extended lifespan, or eliminate PKD.
Nucleus Accumbens Local Circuit for Cue-Dependent Aversive Learning

bioRxiv : the preprint server for biology

2023 Feb 07

Belilos, A;Gray, C;Sanders, C;Richie, C;Sengupta, A;Hake, H;Francis, TC;
PMID: 36798245 | DOI: 10.1101/2023.02.06.527338

Response to threatening environmental stimuli requires holistic detection and encoding of important environmental features that dictate threat. Animals need to recognize the likelihood that an environmental stimulus predicts threat and respond to these salient aversive stimuli appropriately. The nucleus accumbens is uniquely positioned to process this salient, aversive information and promote motivated output, through plasticity on the major projection neurons in the brain area. Here, we uncover a nucleus accumbens core local circuit whereby excitatory plasticity facilitates learning and recall of discrete aversive cues. We demonstrate that nucleus accumbens substance P release and long-term excitatory plasticity on dopamine 2 receptor expressing projection neurons is required for learning about aversion-associated cues. Additionally, we found learning and recall were dependent on different projection-neuron subtypes. Our work demonstrates a critical role for Nucleus Accumbens substance P in cue-dependent aversive learning.
Nucleic Acid Pharmaceutical Agents

Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology

2023 Feb 27

Kohnken, R;Harbison, C;Klein, S;Engelhardt, J;
| DOI: 10.1016/B978-0-12-821047-5.00017-8

Nucleic acid pharmaceutical (NAP) agents are a relatively recent class of therapeutics that are uniquely capable of inhibiting protein translation through direct interaction with RNA. These classes of pharmaceuticals have demonstrated clinical benefit for diseases previously considered untreatable by small molecules and biologics by their theoretical ability to target any cellular RNA associated with disease. This chapter provides an overview of the major types of NAPs and the types of indications for which they are being developed, with examples of therapeutics on the market and in clinical development. The reader is also provided with a review of the most common delivery systems and chemical modifications that enable the biodistribution and efficacy of these drugs. A brief discussion of the nonclinical safety package is provided, and finally the most common toxicities that have been observed in preclinical species are discussed.
Reagents for Mass Cytometry

Chemical reviews

2023 Jan 25

Arnett, LP;Rana, R;Chung, WW;Li, X;Abtahi, M;Majonis, D;Bassan, J;Nitz, M;Winnik, MA;
PMID: 36696538 | DOI: 10.1021/acs.chemrev.2c00350

Mass cytometry (cytometry by time-of-flight detection [CyTOF]) is a bioanalytical technique that enables the identification and quantification of diverse features of cellular systems with single-cell resolution. In suspension mass cytometry, cells are stained with stable heavy-atom isotope-tagged reagents, and then the cells are nebulized into an inductively coupled plasma time-of-flight mass spectrometry (ICP-TOF-MS) instrument. In imaging mass cytometry, a pulsed laser is used to ablate ca. 1 μm2 spots of a tissue section. The plume is then transferred to the CyTOF, generating an image of biomarker expression. Similar measurements are possible with multiplexed ion bean imaging (MIBI). The unit mass resolution of the ICP-TOF-MS detector allows for multiparametric analysis of (in principle) up to 130 different parameters. Currently available reagents, however, allow simultaneous measurement of up to 50 biomarkers. As new reagents are developed, the scope of information that can be obtained by mass cytometry continues to increase, particularly due to the development of new small molecule reagents which enable monitoring of active biochemistry at the cellular level. This review summarizes the history and current state of mass cytometry reagent development and elaborates on areas where there is a need for new reagents. Additionally, this review provides guidelines on how new reagents should be tested and how the data should be presented to make them most meaningful to the mass cytometry user community.
Progenitor-derived endothelin controls dermal sheath contraction for hair follicle regression

Nature cell biology

2023 Jan 30

Martino, P;Sunkara, R;Heitman, N;Rangl, M;Brown, A;Saxena, N;Grisanti, L;Kohan, D;Yanagisawa, M;Rendl, M;
PMID: 36717629 | DOI: 10.1038/s41556-022-01065-w

Substantial follicle remodelling during the regression phase of the hair growth cycle is coordinated by the contraction of the dermal sheath smooth muscle, but how dermal-sheath-generated forces are regulated is unclear. Here, we identify spatiotemporally controlled endothelin signalling-a potent vasoconstriction-regulating pathway-as the key activating mechanism of dermal sheath contraction. Pharmacological blocking or genetic ablation of both endothelin receptors, ETA and ETB, impedes dermal sheath contraction and halts follicle regression. Epithelial progenitors at the club hair-epithelial strand bottleneck produce the endothelin ligand ET-1, which is required for follicle regression. ET signalling in dermal sheath cells and downstream contraction is dynamically regulated by cytoplasmic Ca2+ levels through cell membrane and sarcoplasmic reticulum calcium channels. Together, these findings illuminate an epithelial-mesenchymal interaction paradigm in which progenitors-destined to undergo programmed cell death-control the contraction of the surrounding sheath smooth muscle to orchestrate homeostatic tissue regression and reorganization for the next stem cell activation and regeneration cycle.
Targeting Peripheral μ-opioid Receptors or μ-opioid Receptor-Expressing Neurons Does not Prevent Morphine-induced Mechanical Allodynia and Anti-allodynic Tolerance

Neuroscience bulletin

2023 Jan 09

Du, F;Yin, G;Han, L;Liu, X;Dong, D;Duan, K;Huo, J;Sun, Y;Cheng, L;
PMID: 36622575 | DOI: 10.1007/s12264-022-01009-2

The chronic use of morphine and other opioids is associated with opioid-induced hypersensitivity (OIH) and analgesic tolerance. Among the different forms of OIH and tolerance, the opioid receptors and cell types mediating opioid-induced mechanical allodynia and anti-allodynic tolerance remain unresolved. Here we demonstrated that the loss of peripheral μ-opioid receptors (MORs) or MOR-expressing neurons attenuated thermal tolerance, but did not affect the expression and maintenance of morphine-induced mechanical allodynia and anti-allodynic tolerance. To confirm this result, we made dorsal root ganglia-dorsal roots-sagittal spinal cord slice preparations and recorded low-threshold Aβ-fiber stimulation-evoked inputs and outputs in superficial dorsal horn neurons. Consistent with the behavioral results, peripheral MOR loss did not prevent the opening of Aβ mechanical allodynia pathways in the spinal dorsal horn. Therefore, the peripheral MOR signaling pathway may not be an optimal target for preventing mechanical OIH and analgesic tolerance. Future studies should focus more on central mechanisms.
Leveraging circuits to understand addiction

Neurocircuitry of Addiction

2023 Jan 19

Salling, M;
| DOI: 10.1016/B978-0-12-823453-2.00002-3

Advancements in neuroscientific methods often drive new waves of insight into our understanding of addiction. While addiction research questions persist, technical improvements can augment our observational sensitivity, allowing us to update and extend existing addiction models through method development, creative application, and scientific discovery. As a result of this iterative process, we have reached the point where neuroscientists can now readily identify, monitor, and control specific neural circuits during behavior, thereby opening new windows of inquiry into the neurobiology of addiction. The objective of this chapter is to familiarize the reader with standard and emerging techniques used to observe and interrogate neural circuitry that are prevalent in contemporary clinical and preclinical addiction neuroscience labs and that are presented throughout the book. This chapter will further discuss the historical context, benefits, and limitations of these techniques with a look forward into how they can be applied to questions of addiction neurocircuitry.

Pages

  • « first
  • ‹ previous
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • next ›
  • last »
X
Description
sense
Example: Hs-LAG3-sense
Standard probes for RNA detection are in antisense. Sense probe is reverse complent to the corresponding antisense probe.
Intron#
Example: Mm-Htt-intron2
Probe targets the indicated intron in the target gene, commonly used for pre-mRNA detection
Pool/Pan
Example: Hs-CD3-pool (Hs-CD3D, Hs-CD3E, Hs-CD3G)
A mixture of multiple probe sets targeting multiple genes or transcripts
No-XSp
Example: Hs-PDGFB-No-XMm
Does not cross detect with the species (Sp)
XSp
Example: Rn-Pde9a-XMm
designed to cross detect with the species (Sp)
O#
Example: Mm-Islr-O1
Alternative design targeting different regions of the same transcript or isoforms
CDS
Example: Hs-SLC31A-CDS
Probe targets the protein-coding sequence only
EnEmProbe targets exons n and m
En-EmProbe targets region from exon n to exon m
Retired Nomenclature
tvn
Example: Hs-LEPR-tv1
Designed to target transcript variant n
ORF
Example: Hs-ACVRL1-ORF
Probe targets open reading frame
UTR
Example: Hs-HTT-UTR-C3
Probe targets the untranslated region (non-protein-coding region) only
5UTR
Example: Hs-GNRHR-5UTR
Probe targets the 5' untranslated region only
3UTR
Example: Rn-Npy1r-3UTR
Probe targets the 3' untranslated region only
Pan
Example: Pool
A mixture of multiple probe sets targeting multiple genes or transcripts

Enabling research, drug development (CDx) and diagnostics

Contact Us
  • Toll-free in the US and Canada
  • +1877 576-3636
  • 
  • 
  • 
Company
  • Overview
  • Leadership
  • Careers
  • Distributors
  • Quality
  • News & Events
  • Webinars
  • Patents
Products
  • RNAscope or BaseScope
  • Target Probes
  • Controls
  • Manual assays
  • Automated Assays
  • Accessories
  • Software
  • How to Order
Research
  • Popular Applications
  • Cancer
  • Viral
  • Pathways
  • Neuroscience
  • Other Applications
  • RNA & Protein
  • Customer Innovations
  • Animal Models
Technology
  • Overview
  • RNA Detection
  • Spotlight Interviews
  • Publications & Guides
Assay Services
  • Our Services
  • Biomarker Assay Development
  • Cell & Gene Therapy Services
  • Clinical Assay Development
  • Tissue Bank & Sample Procurement
  • Image Analysis
  • Your Benefits
  • How to Order
Diagnostics
  • Diagnostics
  • Companion Diagnostics
Support
  • Getting started
  • Contact Support
  • Troubleshooting Guide
  • FAQs
  • Manuals, SDS & Inserts
  • Downloads
  • Webinars
  • Training Videos

Visit Bio-Techne and its other brands

  • bio-technie
  • protein
  • bio-spacific
  • rd
  • novus
  • tocris
© 2025 Advanced Cell Diagnostics, Inc.
  • Terms and Conditions of Sale
  • Privacy Policy
  • Security
  • Email Preferences
  • 
  • 
  • 

For Research Use Only. Not for diagnostic use. Refer to appropriate regulations. RNAscope is a registered trademark; and HybEZ, EZ-Batch and DNAscope are trademarks of Advanced Cell Diagnostics, Inc. in the United States and other countries. All rights reserved. ©2025 Advanced Cell Diagnostics, Inc.

 

Contact Us / Request a Quote
Download Manuals
Request a PAS Project Consultation
Order online at
bio-techne.com
OK
X
Contact Us

Complete one of the three forms below and we will get back to you.

For Quote Requests, please provide more details in the Contact Sales form below

  • Contact Sales
  • Contact Support
  • Contact Services
  • Offices

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Bio-Techne

19 Barton Lane  
Abingdon Science Park
Abingdon
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420

 

Advanced Cell Diagnostics China

20F, Tower 3,
Raffles City Changning Office,
1193 Changning Road, Shanghai 200051

021-52293200
info.cn@bio-techne.com
Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com

See Distributors
×

You have already Quick ordered an Item in your cart . If you want to add a new item , Quick ordered Item will be removed form your cart. Do You want to continue?

OK Cancel
Need help?

How can we help you?